7 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Terminated 7 |
| Phase 2 | 2 | Terminated 2 |
Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure "Ex vivo" expanded autologous human oral epithelium containing stem cells - Hypospadias | Phase 1 / Phase 2 | Terminated | Holostem s.r.l. | 1 | 2021-11-26 | 2024-11-12 |
| Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 Abiraterone acetate - Congenital Adrenal Hyperplasia | Phase 1 | Terminated | University of Texas Southwestern Medical Center | 4 | 2017-08-01 | 2025-11-04 |
| Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence MDC - Bladder Exstrophy, Urinary Incontinence | Phase 1 | Terminated | Johns Hopkins University | 2 | 2017-02-01 | 2020-01-28 |
| GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer Ganetespib, Paclitaxel - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | Terminated | Medical University Innsbruck | 133 | 2014-07-04 | 2019-08-13 |
| Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) Salsalate - Polycystic Ovary Syndrome | Phase 1 | Terminated | Indiana University | 47 | 2012-02-01 | 2017-02-10 |
| Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) Anastrozole Pill, Testosterone, Placebo Oral Tablet - Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 1 | Terminated | Massachusetts General Hospital | 7 | 2010-05-01 | 2017-04-18 |
| Initiating Transdermal Estradiol Therapy in Turner's Syndrome Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch - Turner's Syndrome | Phase 1 | Terminated | University of Chicago | 1 | 2009-04-01 | 2014-03-11 |
Adrenal Hyperplasia, Congenital (1) · Bladder Exstrophy (1) · Bladder Exstrophy and Epispadias Complex (1) · Carcinoma, Ovarian Epithelial (1) · Disorders of Sex Development (1) · Fallopian Tube Neoplasms (1) · Hyperandrogenism (1) · Hypogonadism (1) · Hypospadias (1) · Idiopathic Hypogonadotropic Hypogonadism (1) · Inflammation (1) · Insulin Resistance (1) · Kallmann Syndrome (1) · Polycystic Ovary Syndrome (1) · Turner Syndrome (1)
Congenital Abnormalities (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Urogenital Diseases (7) · Endocrine System Diseases (5) · Gonadal Disorders (5) · Disorders of Sex Development (4) · Genetic Diseases, Inborn (3) · Genital Diseases (3) · Adnexal Diseases (2) · Adrenogenital Syndrome (2) · Genital Diseases, Female (2)
Abiraterone Acetate (1) · Anastrozole (1) · Estradiol (1) · Human Growth Hormone (1) · Paclitaxel (1) · STA 9090 (1) · Testosterone (1) · Transdermal Patch (1) · salicylsalicylic acid (1)
Holostem s.r.l. (1) · Indiana University (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · Medical University Innsbruck (1) · University of Chicago (1) · University of Texas Southwestern Medical Center (1)
United States (5) · Austria (1) · Belgium (1) · France (1) · Germany (1) · Italy (1)
Gianantonio Manzoni, MD (1) · Graziella Pellegrini, Professor (1) · John P Gearhart, MD (1) · Nelly Pitteloud, MD (1) · Nicole Concin, MD (1) · Perrin C White, MD (1) · Robert L. Rosenfield, MD (1)
PMID 30590569, PMID 32140727, PMID 32325487
U01HD083493 (1)